1Brady RO,Schiffmann R. Clinical features of and recent advances in therapy for Fabry disease. JAMA, 2000, 284:2771-2775. 被引量:1
2Alroy J, Sabnis S, Kopp JB. Renal pathology in Fabry disease. J Am Soc Nephrol, 2002,13 : 134-138. 被引量:1
3Eng CM,Guffon N,Wilcox WR,et al. Safety andefficacy of recombinant human a-galactosidase A replacement therapy in Fabry's disease. N Engl J Med, 2001,345:9-16. 被引量:1
4Brady RO,Schiffmann R. Clinical features of and recent advances in therapy for Fabry disease. JAMA, 2000,284:2771-2775. 被引量:1
5Alroy J, Sabnis S, Kopp JB. Renal pathology in Fabry disease. J Am Soc Nephrol, 2002,13 : 134-138. 被引量:1
6Eng CM,Guffon N,Wilcox WR,et al. Safety andefficacy of recombinant human a-galactosidase A replacement therapy in Fabry's disease. N Engl J Med,2001,345:9-16. 被引量:1